You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 15, 2024

Drug Sales Trends for OXCARBAZEPIN


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for OXCARBAZEPIN (2021)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $26,579,893
INSIDE ANOTHER STORE $58,924,863
[disabled in preview] $141,846,858
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 379,084
INSIDE ANOTHER STORE 663,570
[disabled in preview] 2,909,826
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $50,391,026
MEDICARE $74,266,992
[disabled in preview] $102,693,596
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for OXCARBAZEPIN
Drug Units Sold Trends for OXCARBAZEPIN

Annual Sales Revenues and Units Sold for OXCARBAZEPIN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2021
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2020
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2019
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2018
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2017
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2016
OXCARBAZEPIN ⤷  Sign Up ⤷  Sign Up 2015
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.